Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06765122 · ClinicalTrials.gov registry record · NA
Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence
A NA study of Interpersonal Violence, sponsored by Cambridge Health Alliance.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT06765122: Active NA study of Interpersonal Violence, sponsored by Cambridge Health Alliance.
NCT06765122 is a NA study of Interpersonal Violence that is active but no longer recruiting, run by Cambridge Health Alliance. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06765122, a NA study of Interpersonal Violence, is active but no longer recruiting, sponsored by Cambridge Health Alliance.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study investigates the feasibility and acceptability of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence.
Primary Outcome
Intervention-based feasibility: 67% (e.g., 8/12) of participants completing at least 67% (e.g., 8/12) of the first 12 groups, study protocol feasibility as 67% (e.g., 8/12) or more of participants completing week-20 study assessments.
Conditions Studied
Interventions
- BEHAVIORAL Program for Alleviating Relationship Trauma and Stress through New Behaviors (PARTS-NB)
Study Locations (2)
Massachusetts
- Cambridge Health Alliance Center for Mindfulness and Compassion - Malden
Washington
- Waterland Counseling - Tumwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-01-08 |
| Est. Completion | 2025-11-16 |
| Phase | NA |
What the registry record for NCT06765122 still lists
NCT06765122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Interpersonal Violence appearing as the primary indexed condition, and to 1 intervention - of which Program for Alleviating Relationship Trauma and Stress through New Behaviors (PARTS-NB) is the first listed.
NCT06765122 reports a single indexed study location in Massachusetts, Washington.
Frequently Asked Questions
What is clinical trial NCT06765122 about?
NCT06765122 is a clinical study titled "Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence". This research study investigates the feasibility and acceptability of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence.
What is the current status of trial NCT06765122?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-01-08. Estimated completion is 2025-11-16.
What conditions does trial NCT06765122 study?
This clinical trial studies the following conditions: Interpersonal Violence.
What interventions are being tested in trial NCT06765122?
The interventions under investigation include: Program for Alleviating Relationship Trauma and Stress through New Behaviors (PARTS-NB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06765122?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06765122 being conducted?
This trial has 2 study locations across Massachusetts, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interpersonal Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06765122's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI